Sonova (OTCMKTS:SONVY) Reaches New 52-Week Low – Time to Sell?

Sonova Holding (OTCMKTS:SONVY) reached a new 52-week low during trading on Monday . The stock traded as low as $47.31 and last traded at $47.31, with a volume of 9453 shares changing hands. The stock had previously closed at $48.82.

Analyst Upgrades and Downgrades

Several research firms have issued reports on SONVY. Zacks Research upgraded Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. BNP Paribas Exane raised Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th. Finally, Royal Bank Of Canada raised Sonova to a “moderate buy” rating in a report on Tuesday, November 18th. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Sonova presently has an average rating of “Moderate Buy”.

Sonova Stock Performance

The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. The firm has a 50-day moving average price of $52.66 and a 200 day moving average price of $53.61.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.